Axis & PartnerRe reaffirm commitment after Exor sweetens deal
Axis and PartnerRe have reaffirmed their commitment to merge, days after Italian investment company Exor sweetened its terms.
Following Exor’s improved offer, which offers a special pre-closing dividend of $3 per share, bringing the total all-cash consideration to $140.50 per share, PartnerRe confirmed it would seek to engage in negotiations with Exor and offer the opportunity to engage in due diligence.
But now, the two Bermuda-based companies have criticised Exor’s proposal on the basis it has “the potential to subject preferred shareholders (and possibly common shareholders) to an onerous annual reporting and penalty regime applicable to prohibited tax shelter transactions under US income tax laws”.
The companies are currently seeking a private letter ruling from the IRS that a change in terms would not create a “listed transaction”.
Jean-Paul Montupet, PartnerRe chairman, said: “Throughout this process, our goal has been to achieve the best value for holders of both our common and preferred shares. We are pleased that we have agreed with Axis Capital to provide our preferred shareholders with a superior proposal and less risk than the proposal put forth by Exor. We must do what is in the best interest of our shareholders and not expose them to risks that may have serious tax and reporting consequences.”
Albert Benchimol, Axis chief executive officer, added: “The strategic and financial benefits of the merger agreement between Axis and PartnerRe continue to represent the most compelling path forward for both companies.
“We are confident that we will be able to provide superior value both to our shareholders and to our clients and distribution partners through the merger, and we are committed to doing so in a manner consistent with our fiduciary responsibilities. I look forward to continuing that process with our colleagues at PartnerRe.”
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze